Timber Pharmaceuticals Past Earnings image   This TMBR past earnings page last updated 11/28/2022
Timber Pharmaceuticals Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/14/2022-1.520
Q2 20228/11/2022-7.500
Q1 20225/12/2022-2.500
Q4 20213/31/2022-2.500
Q3 202111/15/2021-4.000
Q2 20218/10/2021-4.000
Q1 20215/11/2021-2.500
Q4 20203/23/202117.500
Q3 202011/12/20207.000
Q2 20208/18/2020-68.000
Timber Pharmaceuticals Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/14/2022NA
Q2 20228/11/2022NA
Q1 20225/12/20220.08M
Q4 20213/31/20220.00B
Q3 202111/15/20210.00B
Q2 20218/10/20210.00B
Q1 20215/11/20210.04M
Q4 20203/23/20210.00B
Q3 202011/12/20200.00B
Q2 20208/18/2020NA

TMBR Past Earnings Q&A

What was the best and worst TMBR past earnings results?
For Timber Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest TMBR past earnings result in our data set was 17.500/share posted in Q4 2020, while the lowest was in Q2 2020 when TMBR posted -68.000/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2021 when TMBR reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 10 TMBR past earnings results in our data set.

On this page we presented the TMBR past earnings date information for Timber Pharmaceuticals. Reviewing that Timber Pharmaceuticals Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2020, when TMBR posted gaap of 17.500/share. Meanwhile the lowest TMBR past earnings result was in Q2 2020, when TMBR posted gaap of -68.000/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2021 when TMBR reported 0.00B in revenue, while the smallest revenue quarter was Q3 2022 when TMBR reported NA in revenue.

Any self directed investor doing their due diligence on TMBR or any other given stock can benefit from researching all of the Timber Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Timber Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TMBR. Thanks for visiting, and the next time you need to research TMBR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of AEV, NCBS shares outstanding history, Institutional Holders of JUSA.

 

Timber Pharmaceuticals Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.